Historical salary details - Ms. Christine A. Poon, Independent Director, Sherwin-Williams Co.
Ms. Christine A. Poon is the Independent Director of Sherwin-Williams Co.. They also hold 3 other positions in Regeneron Pharmaceuticals, Inc., Neurocrine Biosciences, Inc. and Prudential Financial Inc..
Ms. Christine A. Poon
Independent Director
$ 320.2 K
Gross Remuneration
-
Current Company
Sherwin-Williams Co.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Sherwin-Williams Co. | Independent Director | 320.2 K | 7.1 % |
| 2024 | Regeneron Pharmaceuticals, Inc. | Lead Independent Director | - | - |
| 2024 | Neurocrine Biosciences, Inc. | Independent Director | - | - |
| 2024 | Prudential Financial Inc. | Independent Director | - | - |
| 2023 | Neurocrine Biosciences, Inc. | Independent Director | 813.5 K | - |
| 2023 | Regeneron Pharmaceuticals, Inc. | Lead Independent Director | 748.0 K | 3.9 % |
| 2023 | Prudential Financial Inc. | Independent Director | 337.7 K | -8.7 % |
| 2023 | Sherwin-Williams Co. | Independent Director | 298.9 K | 7.4 % |
| 2023 | Regeneron Pharmaceuticals, Inc. | Lead Independent Director | - | - |
| 2023 | Neurocrine Biosciences, Inc. | Director | - | - |
| 2022 | Regeneron Pharmaceuticals, Inc. | Independent Director | 720.0 K | -0.0 % |
| 2022 | Prudential Financial Inc. | Lead Independent Director | 370 K | -1.3 % |
| 2022 | Sherwin-Williams Co. | Independent Director | 278.2 K | -3.0 % |
| 2021 | Regeneron Pharmaceuticals, Inc. | Independent Director | 720.1 K | 0.0 % |
| 2021 | Prudential Financial Inc. | Lead Independent Director | 375 K | 1.3 % |
| 2021 | Sherwin-Williams Co. | Independent Director | 286.9 K | -1.7 % |
| 2021 | Koninklijke Philips N.V. - ADR | Vice Chairwoman of the Supervisory Board and Secre | 57.4 K | -66.5 % |
| 2020 | Regeneron Pharmaceuticals, Inc. | Independent Director | 720.0 K | 0.0 % |
| 2020 | Prudential Financial Inc. | Lead Independent Director | 370.0 K | 14.7 % |
| 2020 | Sherwin-Williams Co. | Independent Director | 291.8 K | -10.0 % |
| 2020 | Koninklijke Philips N.V. - ADR | Vice Chairwoman of the Supervisory Board and Secre | 171.3 K | -8.5 % |
| 2019 | Regeneron Pharmaceuticals, Inc. | Independent Director | 720.0 K | -41.4 % |
| 2019 | Sherwin-Williams Co. | Independent Director | 324.4 K | 16.1 % |
| 2019 | Prudential Financial Inc. | Independent Director | 322.5 K | 0.0 % |
| 2019 | Koninklijke Philips N.V. - ADR | Vice Chairwoman of the Supervisory Board and Secre | 187.2 K | - |
| 2018 | Regeneron Pharmaceuticals, Inc. | Independent Director | 1.2 M | -6.7 % |
| 2018 | Prudential Financial Inc. | Independent Director | 322.5 K | -0.4 % |
| 2018 | Sherwin-Williams Co. | Independent Director | 279.3 K | -5.7 % |
| 2018 | Koninklijke Philips N.V. - ADR | Vice Chairman of the Supervisory Board and Secreta | - | - |
| 2017 | Regeneron Pharmaceuticals, Inc. | Independent Director | 1.3 M | -37.3 % |
| 2017 | Prudential Financial Inc. | Independent Director | 323.8 K | 0.0 % |
| 2017 | Sherwin-Williams Co. | Independent Director | 296.2 K | 20.9 % |
| 2017 | Koninklijke Philips N.V. - ADR | Vice Chairman of the Supervisory Board and Secreta | - | - |
| 2016 | Regeneron Pharmaceuticals, Inc. | Independent Director | 2.1 M | 1.9 % |
| 2016 | Prudential Financial Inc. | Independent Director | 323.8 K | 0.0 % |
| 2016 | Sherwin-Williams Co. | Independent Director | 245.0 K | -7.0 % |
| 2016 | Koninklijke Philips N.V. - ADR | Vice Chairman of the Supervisory Board and Secreta | - | - |
| 2015 | Regeneron Pharmaceuticals, Inc. | Independent Director | 2.1 M | 16.9 % |
| 2015 | Prudential Financial Inc. | Independent Director | 323.8 K | -0.1 % |
| 2015 | Sherwin-Williams Co. | Independent Director | 263.6 K | 48.4 % |
| 2015 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board, Secretary and Vic | - | - |
| 2014 | Regeneron Pharmaceuticals, Inc. | Independent Director | 1.8 M | 24.3 % |
| 2014 | Prudential Financial Inc. | Independent Director | 324.2 K | 29.0 % |
| 2014 | Sherwin-Williams Co. | Independent Director | 177.7 K | - |
| 2014 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2013 | Regeneron Pharmaceuticals, Inc. | Independent Director | 1.4 M | 175.3 % |
| 2013 | Prudential Financial Inc. | Independent Director | 251.3 K | 4.7 % |
| 2013 | Sherwin-Williams Co. | Independent Director | - | - |
| 2013 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2012 | Regeneron Pharmaceuticals, Inc. | Independent Director | 515.4 K | 43.6 % |
| 2012 | Prudential Financial Inc. | Independent Director | 240 K | 0.0 % |
| 2012 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 91.7 K | -3.5 % |
| 2011 | Regeneron Pharmaceuticals, Inc. | Independent Director | 358.9 K | -8.7 % |
| 2011 | Prudential Financial Inc. | Independent Director | 240 K | 6.7 % |
| 2011 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 95 K | - |
| 2010 | Regeneron Pharmaceuticals, Inc. | Independent Director | 393.2 K | 0.0 % |
| 2010 | Prudential Financial Inc. | Independent Director | 225 K | -1.1 % |
| 2010 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2009 | Regeneron Pharmaceuticals, Inc. | - | 393.2 K | - |
| 2009 | Prudential Financial Inc. | Director | 227.5 K | 3.4 % |
| 2009 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 74 K | - |
| 2008 | Prudential Financial Inc. | Director | 220 K | 34.7 % |
| 2008 | Johnson & Johnson | Vice Chairman of the Board; Worldwide Chairman, Ph | - | - |
| 2007 | Prudential Financial Inc. | Director | 163.3 K | 6.5 % |
| 2007 | Johnson & Johnson | Vice Chairman of the Board; Worldwide Chairman, Ph | - | - |
| 2006 | Prudential Financial Inc. | Director | 153.3 K | - |
| 2006 | Johnson & Johnson | Vice Chairman of the Board of Directors | - | - |
| 2005 | Prudential Financial Inc. | Director | - | - |
| 2005 | Johnson & Johnson | Vice Chairman, Board of Directors; Worldwide Chair | - | - |
| 2004 | Johnson & Johnson | Vice Chairman Worldwide Chairman, Medicines & Nutr | - | - |